Director, Co-CEO and General Counsel · Strata Critical Medical, Inc. · Class A common stock, $0.0001 par value per share
Side
F
Value
$1.58M
Shares
321.8K
Price
$4.92
Executed
Apr 24, 2026
Disclosed
Apr 27, 2026
Disclosure timeline3 days from execution to publication · legal deadline 2 business days
Apr 24 executedApr 27, 2026 disclosed
SRTA · daily
Yahoo Finance chart API
◉This trade, on the day it was made▼Disclosure●Material company filing◯Other disclosed buy◯Other disclosed sellUnofficial public endpoint; daily OHLCV, split-adjusted. Replace with a licensed feed for production.
Tax withholding — administrative, little informational value
Relative size+18 / 25
$1.6M reported value · 20.1% of prior position
Filing timing0 / 15
Disclosed 1 business day after execution (deadline: 2)
Historical behavior+8 / 15
First recorded trade by this actor in this security
Frequency & clustering0 / 15
No clustered activity in the dataset
Market events0 / 10
No material company filing within 60 days after the trade
The Insider Score measures how far a disclosure deviates from normal filing patterns. A high score is a prompt for research, not evidence of illegal insider trading.
Tomkiel Melissa M. filed this Form 4 reporting a tax withholding of SRTA on Apr 24, 2026. It became public on Apr 27, 2026. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.
Extraction
Method
Form 4 XML
Confidence
1.00
Director, Co-CEO and General Counsel
Tomkiel Melissa M.cik:0001859484
Issuer
Strata Critical Medical, Inc.cik:0001779128
Revision history · 0
No field has changed since this record was first ingested.
